Literature DB >> 16519543

Less is more: medicines that require less frequent administration improve adherence, but are they better?

Dyfrig Hughes.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16519543     DOI： 10.2165/00019053-200624030-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  A systematic review of the associations between dose regimens and medication compliance.

Authors:  A J Claxton; J Cramer; C Pierce
Journal:  Clin Ther       Date:  2001-08       Impact factor: 3.393

Review 2.  The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.

Authors:  D A Hughes; A Bagust; A Haycox; T Walley
Journal:  Health Econ       Date:  2001-10       Impact factor: 3.046

3.  Pharmacodynamics of variable patient compliance: implications for pharmaceutical value.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-09-07       Impact factor: 15.470

4.  The odds of the three nons when an aptly prescribed medicine isn't working: non-compliance, non-absorption, non-response.

Authors:  John Urquhart
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

5.  Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.

Authors:  Paul D Miller; Michael R McClung; Liviu Macovei; Jacob A Stakkestad; Marjorie Luckey; Bernard Bonvoisin; Jean-Yves Reginster; Robert R Recker; Claire Hughes; E Michael Lewiecki; Dieter Felsenberg; Pierre D Delmas; David L Kendler; Michael A Bolognese; Nicole Mairon; Cyrus Cooper
Journal:  J Bone Miner Res       Date:  2005-03-14       Impact factor: 6.741

Review 6.  Cost-effectiveness of adherence-enhancing interventions: a quality assessment of the evidence.

Authors:  Rachel A Elliott; Nick Barber; Rob Horne
Journal:  Ann Pharmacother       Date:  2005-01-18       Impact factor: 3.154

7.  Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.

Authors:  Joyce A Cramer; Mayur M Amonkar; Ansgar Hebborn; Roy Altman
Journal:  Curr Med Res Opin       Date:  2005-09       Impact factor: 2.580

Review 8.  Interventions to enhance medication adherence.

Authors:  R B Haynes; X Yao; A Degani; S Kripalani; A Garg; H P McDonald
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 9.  The impact of reducing dose frequency on health outcomes.

Authors:  Anke Richter; Susan F Anton; Susan E Anton; Peter Koch; Susan L Dennett
Journal:  Clin Ther       Date:  2003-08       Impact factor: 3.393

Review 10.  Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review.

Authors:  Gwenn E C Wetzels; Patty Nelemans; Jan S Schouten; Martin H Prins
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844
View more
  8 in total

1.  Estimation of the comparative therapeutic superiority of QD and BID dosing regimens, based on integrated analysis of dosing history data and pharmacokinetics.

Authors:  Laetitia Comté; Bernard Vrijens; Eric Tousset; Paul Gérard; John Urquhart
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-05-12       Impact factor: 2.745

2.  Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens.

Authors:  Dyfrig A Hughes
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

3.  Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).

Authors:  Bernard Vrijens; Marc J Claeys; Victor Legrand; Eef Vandendriessche; Frans Van de Werf
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

4.  Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial.

Authors:  Charles Flexner; Camlin Tierney; Robert Gross; Adriana Andrade; Christina Lalama; Susan H Eshleman; Judith Aberg; Ian Sanne; Teresa Parsons; Angela Kashuba; Susan L Rosenkranz; Anne Kmack; Elaine Ferguson; Marjorie Dehlinger; Donna Mildvan
Journal:  Clin Infect Dis       Date:  2010-04-01       Impact factor: 9.079

5.  When drugs don't work: economic assessment of enhancing compliance with interventions supported by electronic monitoring devices.

Authors:  Dyfrig Hughes
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants.

Authors:  Ali A Alkhafaji; Ludovic Trinquart; Gabriel Baron; Moïse Desvarieux; Philippe Ravaud
Journal:  BMC Med       Date:  2012-11-20       Impact factor: 8.775

7.  Health related quality of life assessment in acute coronary syndrome patients: the effectiveness of early phase I cardiac rehabilitation.

Authors:  Lawrence Anchah; Mohamed Azmi Hassali; Melissa Siaw Han Lim; Mohamed Izham Mohamed Ibrahim; Kui Hian Sim; Tiong Kiam Ong
Journal:  Health Qual Life Outcomes       Date:  2017-01-13       Impact factor: 3.186

8.  Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder.

Authors:  Maximilian Pilhatsch; Tasha Glenn; Natalie Rasgon; Martin Alda; Kemal Sagduyu; Paul Grof; Rodrigo Munoz; Wendy Marsh; Scott Monteith; Emanuel Severus; Rita Bauer; Philipp Ritter; Peter C Whybrow; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2018-05-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.